|
|
 |
| |
Ex- Boston Consulting Group consultant will help build the healthcare strategy consulting firm’s pharmaceutical and biotech practice.
Health Advances strengthens management team
Health Advances, LLC, a leading healthcare strategy consulting firm based in the Boston area, said Christof Marré has joined the firm as a Vice President.
Previously, as Vice President of marketing at Biogen Idec, Marré was responsible for developing and executing the US commercial strategies for Avonex(R) and Tysabri(R), two leading therapies for multiple sclerosis. Marré previously held senior level marketing and strategic planning positions at Corixa Corporation and at Bristol-Myers Squibb. Marré led the Corixa team that worked with Glaxo Smith Kline to Launch Bexxar. At Bristol-Myers Squibb he was Marketing Director for oncology products. Earlier in his career, Marré worked as a strategic management consultant for Monitor Company and for the Boston Consulting Group, with a focus on corporate strategy and M&A.;
Marré studied economics at Bonn University, Germany, and graduated with a Master's degree from the London School of Economics.
“Christof brings to Health Advances broad international pharmaceutical industry experience covering sales, marketing and strategic planning, and expertise in several therapeutic areas,” said Skip Irving, managing director and partner at Health Advances. “His combined consulting and biopharmaceutical industry expertise will prove invaluable to our clients and to our firm as we expand our presence as a leading provider of consulting services focused on the healthcare industry.”
|
|
|
|
|
|
|
